icon3

Antibody Production Market: By Process (Filtration, Downstream Processing, Others) By Type (Monoclonal antibody, Polyclonal antibody) By End User (Research laboratories, Pharmaceutical, and biotechnology companies, Others) Regional Analysis & Forecast - 2026

  • OI-160
  • |
  • Published date: Aug, 2019
  • |
  • Life Sciences & Healthcare
  • |
  • 250 Pages

Introduction


Antibodies are produced by the immune system of an animal in a specific response to a challenge by an immunogen. The immune system acts through two principal mechanisms humoral type responses (production of antibodies) and cell-mediated responses. Immunogens (antigens) are molecules that can induce a specific immune response and are usually foreign proteins or carbohydrates, or sometimes lipids and nucleic acids. The immune systems of mammals are comprised of large numbers of lymphocytes, each characterized by its unique antigen-receptor specificity. This receptor diversity permits immune responses to a broad range of immunogens these factors are driving the market growth.

The overall Global Antibody Production Market was valued at $8.8bn in 2018 and is forecasted to grow at a CAGR of 12.29% between 2018 and 2026, resulting in 2026 global sales of $ 23.22 bn. However, Strict government regulations are restraining the market growth. Moreover, increasing acceptance of targeted therapy is provided ample opportunities for the market.


Antibody Production depending on Type, Monoclonal antibody segment is expected to account for the largest share of the Antibody Production market due to Monoclonal antibodies (mAb) are used extensively in basic biomedical research, in the diagnosis of disease, and in treatment of illnesses, such as infections and cancer.


Segmentation


The Global Antibody Production Market is segmented on the basis of Process, Type, End-User and Region


Based on the Process: Filtration, Multimodal Chromatography Resins, Hydrophobic Interaction, Chromatography (HIC) Resins, Ion Exchange (IEX) Chromatography Resins, Downstream Processing, and Upstream Processing


Based on the Type: Monoclonal antibody and Polyclonal antibody


Based on the End-User: Research laboratories, Pharmaceutical, and biotechnology companies and Other End Users


Based on the Region: North America, Asia-Pacific, Europe, and LAMEA. Among that the Asia Pacific held the largest share of the market due to numerous biopharmaceutical and clinical research associations organizations, which are focusing on Asian nations, for example, China and India for drug discovery and improvement. The existence of less stringent guidelines for antibody advancement and creation, vast genome pool and emerging healthcare infrastructure in this region are the key factors for the development.

The key players in the Global Antibody Production Market include Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation, Eppendorf AG, Bio-Rad Laboratories Inc, Proteogenix and etc..

Report Description: The report covers in-depth analysis of the Global Antibody Production Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by type (Monoclonal antibody and Polyclonal antibody). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.


The report includes in-depth company profiles of key players in the Global Antibody Production Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.


The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.


Scope:



  • Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Antibody Production Market

  • Provides a comparative analysis of key marketed and pipeline products

  • Provides key information on players involved in the Global Antibody Production Market

  • Provides a complete overview of market segments and the regional outlook of Global Antibody Production Market

  • Provides in-depth coverage of key news related to Global Antibody Production Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. Market estimation and forecasting involve the following steps:




  • Data Collation (Primary & Secondary)




  • In-house Estimation (Based on proprietary databases and Models)




  • Market Triangulation




  • Forecasting




  • Market-related information is assembled from both primary and secondary sources. 






  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. 






  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others. 






  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. 





REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$3,850.00
$4,950.00


(For Coporate Licence Only) Complementary
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)